No Data
Ultragenyx Pharmaceutical Analyst Ratings
J.P. Morgan Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $102
Express News | Ultragenyx Pharmaceutical Inc : JP Morgan Cuts Target Price to $102 From $105
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Evercore Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $70
No Data
No Data